JCM | Free Full-Text | Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy | HTML
Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group | British Journal of Ophthalmology
JCM | Free Full-Text | Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
Half-dose photodynamic therapy for serous non-neovascular retinal pigm | OPTH
Half-dose PDT treatment in a 63-year-old male patient with chronic CSC... | Download Scientific Diagram
Half-dose Versus Half-time Photodynamic Therapy for Central Serous Chorioretinopathy. | Semantic Scholar
Eye 2019: One-year results of half-dose photodynamic therapy versus one-third-dose photodynamic therapy in chronic or recurrent
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial - American Journal of Ophthalmology
Changes in PrOs length after PDT in irradiated area in half-fluence and... | Download Table
Five emerging treatments show mixed results
Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients - Ophthalmology Retina
Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy | British Journal of Ophthalmology
PDF) Low-fluence versus half-dose verteporfin PDT for chronic CSC | Dove Medical Press - Academia.edu
Half-dose PDT outperforms subthreshold micropulse laser for central serous chorioretinopathy - American Academy of Ophthalmology
Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy | Eye
Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients - Ophthalmology Retina
3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization | Scientific Reports
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy - Ophthalmology
Half-dose PDT for chronic central serous chorioretinopathy. Summary of... | Download Scientific Diagram
APAO 2017 - Yellow Subthreshold Laser vs PDT in Eyes with Chronic Central Serous Chorioretinopathy - YouTube
Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy | PLOS ONE
Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial | Trials | Full Text
Crossover to Half-dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy patients (SPECS) - ScienceDirect
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy | SpringerLink
Half-dose photodynamic therapy for serous non-neovascular retinal pigm | OPTH
